M&A Deal Summary

LTS Acquires Tapemark

On August 19, 2022, LTS acquired life science company Tapemark

Acquisition Highlights
  • This is LTS’s 1st transaction in the Life Science sector.
  • This is LTS’s 1st transaction in the United States.
  • This is LTS’s 1st transaction in Minnesota.

M&A Deal Summary
Date 2022-08-19
Target Tapemark
Sector Life Science
Buyer(s) LTS
Deal Type Add-on Acquisition

Target

Tapemark

Saint Paul, Minnesota, United States
Tapemark is a full-service CDMO specializing in the innovation of transdermal, oral thin film, and unit dose semi-solid drug delivery. Tapemark was founded in 1952 and is based in Saint Paul, Minnesota.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

LTS

Andernach, Germany
Category Company
Founded 1984
Sector Life Science
DESCRIPTION

LTS is a pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches ("TTS") and Oral Thin Films ("OTF") for the pharmaceutical industry. LTS maintains its leading position through the continuous refinement of its core TTS and OTF technologies and by advancing emerging drug delivery technologies, including Micro Array Patches (MAP) for the transdermal delivery of large molecule, biological actives, and vaccines. LTS was founded in 1984 and is based in Andernach, Germany.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Minnesota) 1 of 1
Country (United States) 1 of 1
Year (2022) 1 of 1
Mergr

Product

Company

Legal